Table 3.
Severity of potential drug–drug interactions (pDDIs; n = 928) among studied chronic kidney disease (CKD) patients.
Severity of pDDIs | N | % |
---|---|---|
Type A (No known interaction) | 11 | 1.2 |
Type B (mild severity) | 84 | 9.1 |
Type C (moderate severity) | 717 | 77.3 |
Type D (major severity) | 106 | 11.4 |
Type X (avoid drug combination) | 10 | 1.1 |